Maureen Miracle Stella
Universitas Katolik Indonesia Atma Jaya

Published : 2 Documents Claim Missing Document
Claim Missing Document
Check
Articles

Found 2 Documents
Search

Perception and Behavior in Skincare Routine During the Covid-19 Pandemic Inneke Jane Hidajat; Maureen Miracle Stella; Jessica Alysia; Maureen Widjaja; Rika Zaskia; Regina Regina
Indonesian Journal of Global Health Research Vol 7 No 3 (2025): Indonesian Journal of Global Health Research
Publisher : GLOBAL HEALTH SCIENCE GROUP

Show Abstract | Download Original | Original Source | Check in Google Scholar | DOI: 10.37287/ijghr.v7i3.6008

Abstract

In the COVID-19 pandemic, several policies have been implemented such as the use of masks and social distancing. This has an impact on lifestyle changes such as skincare routines. The aim of this study was to obtain a demographic, behavioral, and perception overview of skincare use before and during the pandemic in medical students. This cross-sectional study was conducted by distributing a Google form questionnaire to FKIK Unika Atma Jaya students from the 2016-2021 intake. The inclusion criteria used were as follows: (1) FKIK Atma Jaya students from the 2016-2021 intake; (2) Students who completed the questionnaire until the end. Medical students demonstrated a high level of skincare knowledge but showed uncertainty regarding product composition and safety aspects. Their behavior indicated a strong focus on appearance and trust in brand quality, though opinions were divided on halal certification. Despite a strong demand for skincare products, makeup usage declined. Most respondents were aware of skincare benefits and potential side effects, but uncertainty arose about ingredients and disinfecting. This study explored the perceptions and behaviors of medical students regarding skincare use before and during the COVID-19 pandemic. Health promotion is urgently needed to prevent skin disorders due to skincare.
The Therapeutic Effect of Azole and Probiotic Combination on Vulvovaginal Candidiasis: A Literature Review Ummu Aiman; Sahda Alfreda Putri; Jeniffer Handiokho; Efenina Ginting; Agnes Amalia; Maureen Miracle Stella
Indonesian Journal of Global Health Research Vol. 7 No. 6 (2025): Indonesian Journal of Global Health Research
Publisher : GLOBAL HEALTH SCIENCE GROUP

Show Abstract | Download Original | Original Source | Check in Google Scholar | DOI: 10.37287/ijghr.v7i6.640

Abstract

One of the most prevalent vaginal infections in the world is vulvovaginal candidiasis. Due to numerous reported cases of antifungal resistance, a combination treatment with synergistic effect is needed. We aimed to examine the effects of combination therapy involving the administration of azoles and probiotics for treating vulvovaginal candidiasis. A comprehensive search of databases (Google  Scholar,  PubMed,  Wiley, Taylor and Francis, ScienceDirect, and SAGE) using ("Candida" OR "candidiasis") AND ("azole") AND ("probiotic" OR "Lactobacillus") AND ("combination therapy" OR "adjunct treatment") as keywords was performed. Titles and abstracts were reviewed for relevance, followed by full-text screening, without any time limitation (until June 20th, 2025). The inclusion criteria was study published in English about women with vulvovaginal candidiasis receiving azole and probiotic combination as medical treatment. A total of 10 included studies were clinical trials [RCT (n=7) and quasi-experimental (n=3)]. All studies were published between 2015 and 2024. The most commonly used azoles are fluconazole (n=5), clotrimazole (n=4), miconazole (n=1), and the dominant probiotics are Lactobacillus rhamnosus (n=5) and Lactobacillus acidophilus (n=6). Included studies used different azole drugs; most studies used fluconazole orally, either a single dose of 500 mg or 50 mg once daily. Each study combined these azole drugs with probiotics containing several strains via either peroral or pervaginal. The combination of azoles and probiotics can enhance the antifungal effects against candidiasis. Probiotics not only enhance the therapeutic efficacy of vulvovaginal candidiasis treatment but also contribute to reducing the risk of azole resistance.